Last reviewed · How we verify
Exploratory investigation — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Exploratory investigation (Exploratory investigation) — Centre Oscar Lambret.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Exploratory investigation TARGET | Exploratory investigation | Centre Oscar Lambret | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Exploratory investigation CI watch — RSS
- Exploratory investigation CI watch — Atom
- Exploratory investigation CI watch — JSON
- Exploratory investigation alone — RSS
Cite this brief
Drug Landscape (2026). Exploratory investigation — Competitive Intelligence Brief. https://druglandscape.com/ci/exploratory-investigation. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab